World Health Organization site
Skip Navigation Links
Advanced Search
List ByExpand List By
Search Tips
ICTRP websiteExpand ICTRP website
Contact us
                   8495 records for 1684 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02218047
AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease
Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.
Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects with Multiple Sclerosis (ENHANCE)
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT02219932Efficacy and Safety Study of Prolonged-Release Fampridine in Subjects With Multiple Sclerosis18/08/2014
A multicenter, randomized clinical study to see how efficient, safe and well tolerated OCR-002 new drug candidate is in patients who suffer from cirrhosis and high ammonia level in blood with an onset of encephalopathy caused by abnormal liver activity
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis.
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With CKD on Dialysis
Not recruitingNCT02171429
A Study of the Efficacy and Safety of Etrolizumab Treatment, Compared With Adalimumab and Placebo, in Inducing Disease Remission in Ulcerative Colitis Patients Who Have Not Previously Received TNF Inhibitors (Study #2)
A research study to find out whether a product to be tested (salmeterol xinafoate HFA pMDI 25 µg per actuation, manufactured by Cipla Ltd, India) is equivalent to the already existing formulation (salmeterol xinafoate HFA pMDI 25 µg per actuation (Serevent Evohaler™), supplied by Allen and Hanburys, UK) when administered by a volumatic spacer device to children with asthma
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-004766-34-ATSafety and efficacy of LCI699 for the treatment of patients with Cushing's disease31/07/2014
AuthorisedEUCTR2013-004766-34-ESSafety and efficacy of LCI699 for the treatment of patients with Cushing's disease11/08/2014
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history